Flagship Pioneering’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $31.1M | Buy |
|
|||||
|
2023
Q2 | $8.19M | Buy |
|
|||||
|
2023
Q1 | $9.11M | Hold |
|
|||||
|
2022
Q4 | $81.2M | Hold |
|
|||||
|
2022
Q3 | $105M | Hold |
|
|||||
|
2022
Q2 | $106M | Buy |
|
|||||
|
2022
Q1 | $78.1M | Hold |
|
|||||
|
2021
Q4 | $140M | Hold |
|
|||||
|
2021
Q3 | $162M | Hold |
|
|||||
|
2021
Q2 | $316M | Hold |
|
|||||
|
2021
Q1 | $246M | Buy |
|
|||||
|
2020
Q4 | $277M | Hold |
|
|||||
|
2020
Q3 | $121M | Hold |
|
|||||
|
2020
Q2 | $112M | Buy |
|
|||||
|
2020
Q1 | $68.6M | Hold |
|
|||||
|
2019
Q4 | $74M | Hold |
|
|||||
|
2019
Q3 | $111M | Hold |
|
|||||
|
2019
Q2 | $164M | Hold |
|
|||||
|
2019
Q1 | $146M | Hold |
|
|||||
|
2018
Q4 | $237M | Hold |
|
|||||
|
2018
Q3 | $222M | Hold |
|
|||||
|
2018
Q2 | $215M | Buy |
|